{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["breast cancer", "cell cycle arrest", "chick early amniotic fluid", "colon cancer apoptosis", "tumorigenesis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36358278", "DateRevised": {"Year": "2022", "Month": "11", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "27"}], "Language": ["eng"], "ELocationID": ["1577", "10.3390/biology11111577"], "Journal": {"ISSN": "2079-7737", "JournalIssue": {"Volume": "11", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "27"}}, "Title": "Biology", "ISOAbbreviation": "Biology (Basel)"}, "ArticleTitle": "Chick Early Amniotic Fluid (ceAF) Deters Tumorigenesis via Cell Cycle Arrest and Apoptosis.", "Abstract": {"AbstractText": ["In recent years, amniotic fluids have gained attention in cancer research. They have an influential role in protecting embryos against several anomalies. Chick early amniotic fluid (ceAF)-amniotic fluid isolated from growing chicken-has been used in many other studies, including myocardial infarctions and skin regeneration. In this study, we employed ceAF's promising therapeutic applications against tumorigenesis in both in vitro and in vivo studies. We selected three robust proliferating tumor cell lines: BCaP37, MCF7, and RKO. We found that selective dosage is required to obtain maximum impact to deter tumorigenesis. ceAF not only disrupted the uniform colonies of tumor cell lines via disturbing mitochondrial transmembrane potential, but also arrested many cells at growing G1 state via working agonistically with aphidicolin. The significant inhibition of tumor metastasis by ceAF was indicated by in vivo models. This leads to apoptosis analysis as verified by annexin-V staining stays and immunoblotting of critical proteins as cell cycle meditators and apoptosis regulators. Not only on the protein level, but we also tested ceAF's therapeutic potentials on mRNA levels as indicated by quantitative real-time PCR summarizing the promising role of ceAF in deterring tumor progression. In conclusion, our study reveals the potent role of ceAF against tumorigenesis in breast cancer and colon carcinoma. Further studies will be required to determine the critical components present in ceAF and its purification to narrow down this study."]}, "AuthorList": [{"Identifier": ["0000-0002-2415-4181"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National MOE), Zhejiang University School of Medicine, Hangzhou 310058, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Department of Anatomy, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Ahmad", "ForeName": "Mashaal", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Cheng", "ForeName": "Sha", "Initials": "S"}, {"Identifier": ["0000-0002-4632-9392"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China."}], "LastName": "Khan", "ForeName": "Zara Ahmad", "Initials": "ZA"}, {"Identifier": ["0000-0002-3812-8814"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National MOE), Zhejiang University School of Medicine, Hangzhou 310058, China."}], "LastName": "Luo", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": ["0000-0001-6839-1659"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}], "GrantList": [{"GrantID": "(No.QKHZC[2020]4Y161", "Agency": "Science and Technology Planning Project of Guizhou Province", "Country": ""}, {"GrantID": "No. QKHZC [2022]194)", "Agency": "Science and Technology Planning Project of Guizhou Province", "Country": ""}, {"GrantID": "(No. QKHJC -ZK [2022]ZD031", "Agency": "Natural Science Foundation of Guizhou province", "Country": ""}, {"GrantID": "(QKHPTRC-GCC[2022]034-1)", "Agency": "Guizhou province \"Hundred\" level innovative talent training project", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biology (Basel)", "NlmUniqueID": "101587988", "ISSNLinking": "2079-7737"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre L.A., Islami F., Siegel R.L., Ward E.M., Jemal A. Global cancer in women: Burden and trends. Cancer Epidemiol. Biomark. Prev. 2017;26:444\u2013457. doi: 10.1158/1055-9965.EPI-16-0858.", "ArticleIdList": ["10.1158/1055-9965.EPI-16-0858", "28223433"]}, {"Citation": "Kamb A. What\u2019s wrong with our cancer models? Nat. Rev. Drug Discov. 2005;4:161\u2013165. doi: 10.1038/nrd1635.", "ArticleIdList": ["10.1038/nrd1635", "15688078"]}, {"Citation": "Caponigro G., Sellers W.R. Advances in the preclinical testing of cancer therapeutic hypotheses. Nat. Rev. Drug Discov. 2011;10:179\u2013187. doi: 10.1038/nrd3385.", "ArticleIdList": ["10.1038/nrd3385", "21358737"]}, {"Citation": "Bag\u00f3 J.R., Sheets K.T., Hingtgen S.D. Neural stem cell therapy for cancer. Methods. 2016;99:37\u201343. doi: 10.1016/j.ymeth.2015.08.013.", "ArticleIdList": ["10.1016/j.ymeth.2015.08.013", "PMC5436904", "26314280"]}, {"Citation": "Gholizadeh-Ghaleh Aziz S., Fardyazar Z., Pashaiasl M. The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line. Mol. Genet. Genom. Med. 2019;7:e00726. doi: 10.1002/mgg3.726.", "ArticleIdList": ["10.1002/mgg3.726", "PMC6625370", "31111674"]}, {"Citation": "Singh P.K., Srivastava A.K., Dev A., Kaundal B., Choudhury S.R., Karmakar S. 1, 3\u03b2-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy. Carbohydr. Polym. 2018;180:365\u2013375. doi: 10.1016/j.carbpol.2017.10.030.", "ArticleIdList": ["10.1016/j.carbpol.2017.10.030", "29103516"]}, {"Citation": "Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015;65:87\u2013108. doi: 10.3322/caac.21262.", "ArticleIdList": ["10.3322/caac.21262", "25651787"]}, {"Citation": "Wang X., Wang J., Wang Z., Wang Q., Li H. Dynamic monitoring of plasma amino acids and carnitine during chemotherapy of patients with alimentary canal malignancies and its clinical value. Onco Targets Ther. 2015;8:1989\u20131996. doi: 10.2147/OTT.S86562.", "ArticleIdList": ["10.2147/OTT.S86562", "PMC4535544", "26300648"]}, {"Citation": "Tomida C., Aibara K., Yamagishi N., Yano C., Nagano H., Abe T., Ohno A., Hirasaka K., Nikawa T., Teshima-Kondo S. The malignant progression effects of regorafenib in human colon cancer cells. J. Med. Investig. 2015;62:195\u2013198. doi: 10.2152/jmi.62.195.", "ArticleIdList": ["10.2152/jmi.62.195", "26399347"]}, {"Citation": "Mantawy E.M., Esmat A., El-Bakly W.M., ElDin R.A.S., El-Demerdash E. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. Sci. Rep. 2017;7:4795. doi: 10.1038/s41598-017-05005-9.", "ArticleIdList": ["10.1038/s41598-017-05005-9", "PMC5500480", "28684738"]}, {"Citation": "Zhang S.-Y., Li X.-B., Hou S.-G., Sun Y., Shi Y.-R., Lin S.-S. Cedrol induces autophagy and apoptotic cell death in A549 non-small cell lung carcinoma cells through the P13K/Akt signaling pathway, the loss of mitochondrial transmembrane potential and the generation of ROS. Int. J. Mol. Med. 2016;38:291\u2013299. doi: 10.3892/ijmm.2016.2585.", "ArticleIdList": ["10.3892/ijmm.2016.2585", "27177023"]}, {"Citation": "Asim M., Tarish F., Zecchini H.I., Sanjiv K., Gelali E., Massie C.E., Baridi A., Warren A.Y., Zhao W., Ogris C., et al. Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nat. Commun. 2017;8:374. doi: 10.1038/s41467-017-00393-y.", "ArticleIdList": ["10.1038/s41467-017-00393-y", "PMC5575038", "28851861"]}, {"Citation": "Chazotte B. Labeling mitochondria with MitoTracker dyes. Cold Spring Harb. Protoc. 2011;2011:990\u2013992. doi: 10.1101/pdb.prot5648.", "ArticleIdList": ["10.1101/pdb.prot5648", "21807856"]}, {"Citation": "Gumireddy K., Reddy M.R., Cosenza S.C., Nathan R.B., Baker S.J., Papathi N., Jiang J., Holland J., Reddy E.P. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 2005;7:275\u2013286. doi: 10.1016/j.ccr.2005.02.009.", "ArticleIdList": ["10.1016/j.ccr.2005.02.009", "15766665"]}, {"Citation": "van Engeland M., Ramaekers F.C., Schutte B., Reutelingsperger C.P. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 1996;24:131\u2013139. doi: 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M.", "ArticleIdList": ["10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M", "8725662"]}, {"Citation": "Schwartz L.H., Liti\u00e8re S., De Vries E., Ford R., Gwyther S., Mandrekar S., Shankar L., Bogaerts J., Chen A., Dancey J., et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur. J. Cancer. 2016;62:132\u2013137. doi: 10.1016/j.ejca.2016.03.081.", "ArticleIdList": ["10.1016/j.ejca.2016.03.081", "PMC5737828", "27189322"]}, {"Citation": "Rio D.C., Ares M., Jr., Hannon G.J., Nilsen T.W. Purification of RNA using TRIzol (TRI reagent) Cold Spring Harb. Protoc. 2010;2010:pdb.prot5439. doi: 10.1101/pdb.prot5439.", "ArticleIdList": ["10.1101/pdb.prot5439", "20516177"]}, {"Citation": "Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u2013111. doi: 10.1038/35102167.", "ArticleIdList": ["10.1038/35102167", "11689955"]}, {"Citation": "Hoffmeyer K., Raggioli A., Rudloff S., Anton R., Hierholzer A., Del Valle I., Hein K., Vogt R., Kemler R. Wnt/\u03b2-catenin signaling regulates telomerase in stem cells and cancer cells. Science. 2012;336:1549\u20131554. doi: 10.1126/science.1218370.", "ArticleIdList": ["10.1126/science.1218370", "22723415"]}, {"Citation": "Corsten M.F., Shah K. Therapeutic stem-cells for cancer treatment: Hopes and hurdles in tactical warfare. Lancet Oncol. 2008;9:376\u2013384. doi: 10.1016/S1470-2045(08)70099-8.", "ArticleIdList": ["10.1016/S1470-2045(08)70099-8", "18374291"]}, {"Citation": "Johnson L.V., Walsh M.L., Chen L.B. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. USA. 1980;77:990\u2013994. doi: 10.1073/pnas.77.2.990.", "ArticleIdList": ["10.1073/pnas.77.2.990", "PMC348409", "6965798"]}, {"Citation": "Kim M., Cooper D.D., Hayes S.F., Spangrude G.J. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood J. Am. Soc. Hematol. 1998;91:4106\u20134117.", "ArticleIdList": ["9596656"]}, {"Citation": "Head T., Dau P., Duffort S., Daftarian P., Joshi P.M., Vazquez-Padron R., Deo S.K., Daunert S. An enhanced bioluminescence-based Annexin V probe for apoptosis detection in vitro and in vivo. Cell Death Dis. 2017;8:e2826. doi: 10.1038/cddis.2017.141.", "ArticleIdList": ["10.1038/cddis.2017.141", "PMC5520691", "28542141"]}, {"Citation": "Baldin V., Lukas J., Marcote M.J., Pagano M., Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812\u2013821. doi: 10.1101/gad.7.5.812.", "ArticleIdList": ["10.1101/gad.7.5.812", "8491378"]}, {"Citation": "Keyomarsi K., Herliczek T.W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 1997;3:171\u2013191.", "ArticleIdList": ["9552414"]}, {"Citation": "Kern M.A., Haugg A.M., Koch A.F., Schilling T., Breuhahn K., Walczak H., Fleischer B., Trautwein C., Michalski C., Schulze-Bergkamen H., et al. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res. 2006;66:7059\u20137066. doi: 10.1158/0008-5472.CAN-06-0325.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0325", "16849551"]}, {"Citation": "Finucane D.M., Bossy-Wetzel E., Waterhouse N.J., Cotter T.G., Green D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 1999;274:2225\u20132233. doi: 10.1074/jbc.274.4.2225.", "ArticleIdList": ["10.1074/jbc.274.4.2225", "9890985"]}, {"Citation": "Hoffman B., A Liebermann D. Apoptotic signaling by c-MYC. Oncogene. 2008;27:6462\u20136472. doi: 10.1038/onc.2008.312.", "ArticleIdList": ["10.1038/onc.2008.312", "18955973"]}, {"Citation": "Baek S.H., Lee J.H., Kim C., Ko J.-H., Ryu S.-H., Lee S.-G., Yang W.M., Um J.-Y., Chinnathambi A., Alharbi S.A., et al. Ginkgolic acid C 17:1, derived from Ginkgo biloba leaves, suppresses constitutive and inducible STAT3 activation through induction of PTEN and SHP-1 tyrosine phosphatase. Molecules. 2017;22:276. doi: 10.3390/molecules22020276.", "ArticleIdList": ["10.3390/molecules22020276", "PMC6155672", "28208828"]}, {"Citation": "Singh R.P., Dhanalakshmi S., Agarwal R. Phytochemicals as Cell Cycle Modulators A Less Toxic Approach in Halting Human Cancers. Cell Cycle. 2002;1:155\u2013160. doi: 10.4161/cc.1.3.117.", "ArticleIdList": ["10.4161/cc.1.3.117", "12429925"]}, {"Citation": "Barbieri F., Lorenzi P., Ragni N., Schettini G., Bruzzo C., Pedull\u00e0 F., Alama A. Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian Cancer. Oncology. 2004;66:310\u2013315. doi: 10.1159/000078332.", "ArticleIdList": ["10.1159/000078332", "15218299"]}, {"Citation": "Ahmad M., Sun Y., Jia X., Li J., Zhang L., Yang Z., Lin Y., Zhang X., Khan Z.A., Qian J., et al. Therapeutic values of chick early amniotic fluid (ceAF) that facilitates wound healing via potentiating a SASP-mediated transient senescence. Genes Dis. 2021;9:1345\u20131356. doi: 10.1016/j.gendis.2021.03.003.", "ArticleIdList": ["10.1016/j.gendis.2021.03.003", "PMC9293714", "35873014"]}, {"Citation": "Cui B., Zheng Y., Gao X., Zhang L., Li B., Chen J., Zhou X., Cai M., Sun W., Zhang Y., et al. Therapeutic application of chick early amniotic fluid: Effective rescue of acute myocardial ischemic injury by intravenous administration. Cell Regen. 2022;11:9. doi: 10.1186/s13619-022-00110-1.", "ArticleIdList": ["10.1186/s13619-022-00110-1", "PMC8975954", "35362769"]}, {"Citation": "Kim J., Lee Y., Kim H., Hwang K.J., Kwon H.C., Kim S.K., Cho D.J., Kang S.G., You J. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007;40:75\u201390. doi: 10.1111/j.1365-2184.2007.00414.x.", "ArticleIdList": ["10.1111/j.1365-2184.2007.00414.x", "PMC6496664", "17227297"]}, {"Citation": "Mehta R.G., Murillo G., Naithani R., Peng X. Cancer chemoprevention by natural products: How far have we come? Pharm. Res. 2010;27:950\u2013961. doi: 10.1007/s11095-010-0085-y.", "ArticleIdList": ["10.1007/s11095-010-0085-y", "20238150"]}, {"Citation": "Weyerh\u00e4user P., Kantelhardt S.R., Kim E.L. Re-purposing chloroquine for glioblastoma: Potential merits and confounding variables. Front. Oncol. 2018;8:335. doi: 10.3389/fonc.2018.00335.", "ArticleIdList": ["10.3389/fonc.2018.00335", "PMC6120043", "30211116"]}, {"Citation": "Schwartz G.K., Shah M.A. Targeting the cell cycle: A new approach to cancer therapy. J. Clin. Oncol. 2005;23:9408\u20139421. doi: 10.1200/JCO.2005.01.5594.", "ArticleIdList": ["10.1200/JCO.2005.01.5594", "16361640"]}, {"Citation": "Dai W. Polo-like kinases, an introduction. Oncogene. 2005;24:214\u2013216. doi: 10.1038/sj.onc.1208270.", "ArticleIdList": ["10.1038/sj.onc.1208270", "15640836"]}, {"Citation": "Holtrich U., Wolf G., Br\u00e4uninger A., Karn T., B\u00f6hme B., R\u00fcbsamen-Waigmann H., Strebhardt K. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc. Natl. Acad. Sci. USA. 1994;91:1736\u20131740. doi: 10.1073/pnas.91.5.1736.", "ArticleIdList": ["10.1073/pnas.91.5.1736", "PMC43238", "8127874"]}, {"Citation": "Erikson E., Haystead T.A.J., Qian Y.-W., Maller J.L. A feedback loop in the polo-like kinase activation pathway. J. Biol. Chem. 2004;279:32219\u201332224. doi: 10.1074/jbc.M403840200.", "ArticleIdList": ["10.1074/jbc.M403840200", "15166215"]}, {"Citation": "Boya P., Gonzalez-Polo R.A., Poncet D., Andreau K., Vieira H.L., Roumier T., Perfettini J.L., Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 2003;22:3927\u20133936. doi: 10.1038/sj.onc.1206622.", "ArticleIdList": ["10.1038/sj.onc.1206622", "12813466"]}, {"Citation": "Zamzami N., Susin S.A., Marchetti P., Hirsch T., G\u00f3mez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 1996;183:1533\u20131544. doi: 10.1084/jem.183.4.1533.", "ArticleIdList": ["10.1084/jem.183.4.1533", "PMC2192517", "8666911"]}, {"Citation": "Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 1998;281:1309\u20131312. doi: 10.1126/science.281.5381.1309.", "ArticleIdList": ["10.1126/science.281.5381.1309", "9721092"]}, {"Citation": "Krtolica A., Parrinello S., Lockett S., Desprez P.-Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc. Natl. Acad. Sci. USA. 2001;98:12072\u201312077. doi: 10.1073/pnas.211053698.", "ArticleIdList": ["10.1073/pnas.211053698", "PMC59769", "11593017"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "30"}, {"Year": "2022", "Month": "10", "Day": "14"}, {"Year": "2022", "Month": "10", "Day": "20"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "4"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["36358278", "PMC9687777", "10.3390/biology11111577", "biology11111577"]}}], "PubmedBookArticle": []}